We observed tumor-specific methylation of DACT1 in breast cancer, indicating its potential as a tumor marker, although no obvious correlation between its methylation and clinicopathologic features was found, which must be further confirmed by a large sample-sized study. This evidence concerns the gene DACT1 and breast carcinoma.